Drug reference
menotropins
Gonadotropin · Ovarian stimulation, in vitro fertilization
GonadotropinOvarian stimulation, in vitro fertilization
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Menotropins are preparations derived from human urine that contain roughly equal amounts of FSH and LH activity, used to promote follicle maturation.
Indications
Ovarian stimulationIn vitro fertilizationAmenorrhoea (due to deficient pituitary Gns)Infertility (due to deficient pituitary Gns, or clomiphene failure, or polycystic ovaries)To aid in vitro fertilization
Dosing
- Adult
- Administered intramuscularly.
Pharmacokinetics
Half-life
2–6 hours
Excretion
Partly metabolized, but mainly excreted unchanged in urine
Contraindications
- Hormone dependent malignancies (prostate, breast)
Side effects
Common
EdemaHeadacheMood changesAllergic reactions
Serious
- Ovarian hyperstimulation (polycystic ovary, pain in lower abdomen, ovarian bleeding, shock)
- Multiple pregnancy
- Abortion
- Precocious puberty (in children)
Related guidelines
Ask House about menotropins
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team